With 150.29M Outstanding Shares, Can Heron Therapeutics Inc (NASDAQ: HRTX) Deliver Big Short-Term Gains?

Heron Therapeutics Inc (NASDAQ:HRTX) currently has a daily average trading volume of 2.49M but it saw 1346797 shares traded in last market. With a market cap of 546.86M USD, the company’s current market price of $3.63 came falling about -4.97 while comparing to the previous closing price of $3.82. In past 52 weeks, the stock remained buoying in the range of price level as high as $3.90 and as low as $0.50.

Taking a look at 20-day trading activity of Heron Therapeutics Inc (HRTX) gives us an average price of $3.34, while its current price level is -6.92% below from 52-week high level whereas it is 626.00% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $2.95 while that of 200 days or SMA-200 reads an average of $2.01. A closer look into the stock’s movement over the week reveals that its volatility is standing at 7.44% during that period while stretching the period over a month that decreases to 6.66%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 60.25 which implies that the stock is in neutral territory.

The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the CapitalOne which initiated the stock as “Overweight” in its note to investors issued on April 23, 2024, recommending a price target of $6 for it. Guggenheim also issued its recommendations for the stock as it initiated the price target for the stock is $24.

Over the week, HRTX’s stock price is moving 5.22% up while it is 26.48% when we observe its performance for the past one month. Year-to-date it is 113.53% up and over the past year, the stock is showing an upside performance of 227.03%.

Currently, Heron Therapeutics Inc’s total number of outstanding shares is 150.29M. Company’s return on investment (ROI) stands at -56.90% and return on equity (ROE) at -2408.88%. It has a 371.17 of forward P/E ratio. Stock’s beta reads 1.82. Stock has a price to sale or P/S ratio amounts to 4.14. Its return on asset (ROA) is -36.90% on average.